Although, iPSCs research has been a revolution in the scientific field as it provides new hope for the treatment of many diseases, protocols describing the differentiation of iPSCs into neural cells in neurodegenerative diseases and in the context of neurotrauma are still being modified and studied to assess the effect of this process on gene mutations in these cells and vice versa. Advances have been made recently to uncover the underlying molecular pathways of several neurodegenerative diseases, yet more work has to be done before one can say complete cure from such disorders is possible.
